Loading...
Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design
[Image: see text] Current treatment of toxoplasmosis targets the parasite’s folate metabolism through inhibition of dihydrofolate reductase (DHFR). The most widely used DHFR antagonist, pyrimethamine, was introduced over 60 years ago and is associated with toxicity that can be largely attributed to...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Chemical
Society
2016
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5150685/ https://ncbi.nlm.nih.gov/pubmed/27994750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00328 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|